Evidence map›Paper›PMID 38366099›Full record

ArticleScientific reports2024

Macrolide and lincosamide resistance of Streptococcus agalactiae in pregnant women in Poland.

Dorota Kamińska, Magdalena Ratajczak, Dorota M Nowak-Malczewska, Justyna A Karolak, Marek Kwaśniewski, Anna Szumala-Kakol, Jolanta Dlugaszewska, Marzena Gajecka

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Vaginal Colonization byInfection and drug resistance · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Identification and antimicrobial susceptibility testing ofIranian journal of microbiology · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Regulation of erm(T) MLSnpj antimicrobials and resistance · 2024
    Article
  19. Prevalence and Antibiotic Resistance ofLife (Basel, Switzerland) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dorota KamińskaChair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Magdalena RatajczakChair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Dorota M Nowak-MalczewskaChair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Justyna A KarolakChair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Marek KwaśniewskiChair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Anna Szumala-KakolUnit of Microbiology, Gynecological and Obstetric Clinical Hospital, Poznan University of Medical Sciences, Polna 33, 60-535, Poznan, Poland.
Jolanta DlugaszewskaChair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland.
Marzena GajeckaChair and Department of Genetics and Pharmaceutical Microbiology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, 60-806, Poznan, Poland. gamar@man.poznan.pl.ORCID 0000-0001-7468-2604
Poznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Knowing about the antibiotic resistance, serotypes, and virulence-associated genes of Group B Streptococcus for epidemiological and vaccine development is very important. We have determined antimicrobial susceptibility patterns, serotype, and virulence profiles. The antibiotic susceptibility was assessed for a total of 421 Streptococcus agalactiae strains, isolated from pregnant women and neonates. Then, 89 erythromycin and/or clindamycin-resistant strains (82 isolates obtained from pregnant women and seven isolates derived from neonates) were assessed in detail. PCR techniques were used to identify the studied strains, perform serotyping, and assess genes encoding selected virulence factors. Phenotypic and genotypic methods determined the mechanisms of resistance. All tested strains were sensitive to penicillin and levofloxacin. The constitutive MLS

Indexed as

Anti-Bacterial AgentsStreptococcal InfectionsClindamycinDrug Resistance, BacterialErythromycinFemaleHumansInfant, NewbornLincosamidesMacrolidesMicrobial Sensitivity TestsPolandPregnancyPregnant PeopleStreptococcus agalactiaeAnti-Bacterial AgentsClindamycinErythromycinLincosamidesMacrolidesAntimicrobial susceptibility patternsGroup B StreptococcusLincosamide resistanceMacrolide resistanceSerotypingStreptogramin resistanceVirulence factors

Identifiers

PMID38366099
PMCPMC10873391
OpenAlexW4391879684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.